| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |